Acute Systemic Toxicity Study
Materials Required
/
Principle
Acute systemic toxicity studies evaluate adverse effects occurring after a single exposure, or repeated exposure within a short acute window, and the main in vivo readouts are mortality, moribund condition, clinical signs, body-weight change, and gross pathological findings; acute oral toxicity methods were developed to replace classical LD50 testing with reduced-animal designs such as fixed-dose procedure, acute toxic class method, and up-and-down procedure[1][2][3][4][5][6][7]. The fixed-dose procedure classifies acute toxicity by administering predefined dose levels and observing evident toxicity rather than using death as the primary endpoint, whereas the acute toxic class method uses sequential groups of three animals per step and the up-and-down procedure doses animals sequentially to estimate an LD50 with fewer animals than conventional LD50 testing[2][5][6].
MCE has not independently verified the accuracy of these methods. They are for reference only.
Experimental Materials
• Use the test article, a literature-justified vehicle compatible with the test route, and dosing formulations prepared to deliver the selected dose levels; published acute oral toxicity methods support predefined or sequential dose selection rather than unsupported exploratory dosing[2][3][5][6].
• The supported endpoints are clinical observation, survival/moribund status, body weight, and gross necropsy[1][2][5][6].
• Use calibrated animal weighing equipment, appropriate dosing equipment for the selected exposure route, observation records, and necropsy tools, because the supported outputs are dose administered, animal status, body-weight change, clinical signs, and gross pathological findings[1][2][5][6].
• The supported endpoints are clinical observation, survival/moribund status, body weight, and gross necropsy[1][2][5][6].
• Use calibrated animal weighing equipment, appropriate dosing equipment for the selected exposure route, observation records, and necropsy tools, because the supported outputs are dose administered, animal status, body-weight change, clinical signs, and gross pathological findings[1][2][5][6].
Experimental Procedure
• Select a rodent model and sex based on the specific acute toxicity design; the up-and-down comparison reported that one sex was sufficient in most cases and that females are often more sensitive when sex differences occur, while acute toxic class validation used three animals per step[5][6].
• Prepare the test article in the chosen vehicle immediately according to stability and compatibility information available for the substance; do not proceed with dosing levels known to cause marked pain, severe distress, corrosive injury, or severe irritation, because humane endpoints are required for moribund animals or animals showing severe and enduring distress[6].
• For a fixed-dose approach, conduct a sighting or starting-dose stage followed by a main study at a predefined dose level; published validation and statistical evaluations show that the fixed-dose procedure can classify acute oral toxicity with fewer animals than classical LD50 testing, but the starting dose can affect classification[2][3][4].
• For an acute toxic class approach, dose three animals of one sex per step at fixed dose levels and proceed stepwise according to mortality or moribund status; the international validation study reported fixed doses of 25, 200, and 2000 mg/kg, with optional additional fixed doses of 5, 50, and 500 mg/kg for refinement or specific classification cutoffs[6].
• For an up-and-down approach, dose animals sequentially and adjust the next dose based on survival or death of the previous animal; comparative evaluation found that the UDP required six to ten animals of one sex and provided an LD50 estimate while maintaining classification consistency with conventional LD50 results in most tested cases[5].
• Observe animals after dosing for survival, moribund condition, clinical signs, and body-weight change, and perform gross necropsy at death or scheduled termination, because these are the repeatedly reported biological readouts used to determine acute systemic toxicity and classify hazard[1][2][5][6][7].
• Classify the test article by integrating dose level, mortality or moribund outcome, clinical signs, body-weight change, and necropsy findings; the ATC method is intended for toxicity class allocation, the FDP supports acute toxicity ranking without death as the primary endpoint, and the UDP can provide an LD50 estimate[2][5][6].
• Interpret borderline classifications cautiously because rat acute oral LD50 datasets show substantial inter-study variability, and repeated in vivo acute oral toxicity measurements may differ due to inherent biological or protocol variability[7].
• Prepare the test article in the chosen vehicle immediately according to stability and compatibility information available for the substance; do not proceed with dosing levels known to cause marked pain, severe distress, corrosive injury, or severe irritation, because humane endpoints are required for moribund animals or animals showing severe and enduring distress[6].
• For a fixed-dose approach, conduct a sighting or starting-dose stage followed by a main study at a predefined dose level; published validation and statistical evaluations show that the fixed-dose procedure can classify acute oral toxicity with fewer animals than classical LD50 testing, but the starting dose can affect classification[2][3][4].
• For an acute toxic class approach, dose three animals of one sex per step at fixed dose levels and proceed stepwise according to mortality or moribund status; the international validation study reported fixed doses of 25, 200, and 2000 mg/kg, with optional additional fixed doses of 5, 50, and 500 mg/kg for refinement or specific classification cutoffs[6].
• For an up-and-down approach, dose animals sequentially and adjust the next dose based on survival or death of the previous animal; comparative evaluation found that the UDP required six to ten animals of one sex and provided an LD50 estimate while maintaining classification consistency with conventional LD50 results in most tested cases[5].
• Observe animals after dosing for survival, moribund condition, clinical signs, and body-weight change, and perform gross necropsy at death or scheduled termination, because these are the repeatedly reported biological readouts used to determine acute systemic toxicity and classify hazard[1][2][5][6][7].
• Classify the test article by integrating dose level, mortality or moribund outcome, clinical signs, body-weight change, and necropsy findings; the ATC method is intended for toxicity class allocation, the FDP supports acute toxicity ranking without death as the primary endpoint, and the UDP can provide an LD50 estimate[2][5][6].
• Interpret borderline classifications cautiously because rat acute oral LD50 datasets show substantial inter-study variability, and repeated in vivo acute oral toxicity measurements may differ due to inherent biological or protocol variability[7].
Troubleshooting
Problem: Severe clinical signs appear at the selected starting dose.
• Possible Cause: The starting dose was too high or the substance produces marked distress at that exposure level.• Literature-supported Solution: Stop escalation, apply humane endpoints for moribund or severely distressed animals, and use a lower supported dose level or a sequential design that avoids repeating a lethal dose[3][6].
Problem: Classification is uncertain after a fixed-dose design.
• Possible Cause: The starting dose can affect fixed-dose classification.• Literature-supported Solution: Interpret the result using the predefined decision logic of the fixed-dose design and avoid unsupported post hoc dose changes[3].
Problem: LD50 values or hazard categories differ from earlier reports.
• Possible Cause: Acute oral toxicity datasets show substantial variability across rat studies.• Literature-supported Solution: Report the full study design, species/strain/sex, dose levels, vehicle, clinical signs, mortality, body weight, and necropsy findings so that variability can be evaluated transparently[7].
References:
- [1]. Walum E. Acute oral toxicity. Environ Health Perspect. 1998;106 Suppl 2:497-503. [Content Brief]
- [2]. van den Heuvel MJ, Clark DG, Fielder RJ, Koundakjian PP, Oliver GJ, Pelling D, et al. The international validation of a fixed-dose procedure as an alternative to the classical LD50 test. Food Chem Toxicol. 1990;28(7):469-482. [Content Brief]
- [3]. Whitehead A, et al. Statistical evaluation of the fixed-dose procedure. Food Chem Toxicol. 1992;30(4):313-324. [Content Brief]
- [4]. Stallard N, et al. Reducing animal numbers in the fixed-dose procedure. Hum Exp Toxicol. 1995;14(4):315-323. [Content Brief]
- [5]. Lipnick RL, Cotruvo JA, Hill RN, Bruce RD, Stitzel KA, Walker AP, et al. Comparison of the up-and-down, conventional LD50, and fixed-dose acute toxicity procedures. Food Chem Toxicol. 1995;33(3):223-231. [Content Brief]
- [6]. Schlede E, et al. The international validation study of the acute toxic class method (oral). Arch Toxicol. 1995;69(10):659-670. [Content Brief]
- [7]. Karmaus AL, Mansouri K, To KT, Blake B, Fitzpatrick J, Strickland J, et al. Evaluation of variability across rat acute oral systemic toxicity studies. Toxicol Sci. 2022;188(1):34-47. [Content Brief]
LinkedIn
Researchgate
Instagram
X
Facebook
WhatsApp
Reddit
Mail